Close
Nordic 9Nordic 9

Sitryx Therapeutics (private company)

United Kingdom sitryx.com
See something wrong or missing? Let us know
Offices:Oxford
Industry:BiotechHealth servicesManufacturingPharma
Business model:B2B

Sitryx is a British biopharmaceutical company develops disease modifying therapeutics in immuno-oncology and immuno-inflammation.

Investors: we tracked 5 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 39.68M

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to Sitryx Therapeutics

Name Criteria
France AbolerIS Pharma
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
United Kingdom Beckley Psytech
67%
  • Similar verticals: Health services, Manufacturing, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
Germany CatalYm
67%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Sweden Cinclus Pharma
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
France InnovaFeed SAS
67%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Switzerland Memo Therapeutics
67%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Denmark NMD Pharma
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
United Kingdom Peptone
67%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 10M+ USD
United Kingdom ReViral
67%
  • Similar verticals: Biotech, Health services, Pharma
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 3
  • Total raised in a similar range: 10M+ USD
Netherlands Salvia BioElectronics
67%
  • Similar verticals: Biotech, Health services, Manufacturing
  • Similar business models: B2B
  • At least one vc investor: found 2
  • At least one other investor: found 1
  • Total raised in a similar range: 10M+ USD
Top